# ENgineered Tissue Repair of BronchopleUral FiSTula

> **NCT04435249** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Videregen Limited**

## Conditions studied

- Bronchopleural Fistula

## Interventions

- **OTHER:** BPF-001

## Key facts

- **NCT ID:** NCT04435249
- **Lead sponsor:** Videregen Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-10
- **Primary completion:** 2027-03
- **Final completion:** 2028-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding constraints
- **Last updated:** 2025-04-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04435249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04435249, "ENgineered Tissue Repair of BronchopleUral FiSTula". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04435249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*